Testosterone Concentrations and Cardiovascular Autonomic Neuropathy in Men with Type 1 Diabetes in the Epidemiology of Diabetes Interventions and Complications Study (EDIC).

PubWeight™: 0.76‹?›

🔗 View Article (PMID 26559501)

Published in J Sex Med on November 12, 2015

Authors

Catherine Kim1, Rodica Pop-Busui2, Barbara Braffett3, Patricia A Cleary3, Ionut Bebu3, Hunter Wessells4, Trevor Orchard5, Aruna V Sarma6, DCCT/E.D.I.C. Research Group

Author Affiliations

1: Departments of Medicine, Obstetrics and Gynecology, and Epidemiology, University of Michigan, Ann Arbor, MI, USA.
2: Department of Medicine, University of Michigan, Ann Arbor, MI, USA.
3: The Biostatistics Center, George Washington University, Rockville, MD, USA.
4: Department of Urology, University of Washington, Seattle, WA, USA.
5: Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA, USA.
6: Department of Urology, University of Michigan, Ann Arbor, MI, USA.

Associated clinical trials:

Epidemiology of Diabetes Interventions and Complications (EDIC) | NCT00360893

Diabetes Control and Complications Trial (DCCT) | NCT00360815

Articles cited by this

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 102.56

Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA (2013) 12.37

A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab (1999) 10.64

Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care (1999) 8.33

Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2010) 7.15

Diabetic autonomic neuropathy. Diabetes Care (2003) 6.59

Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2006) 5.58

Diabetic cardiovascular autonomic neuropathy. Circulation (2007) 4.58

Hemoglobin A1c measurements over nearly two decades: sustaining comparable values throughout the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study. Clin Chem (2005) 3.15

Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. J Am Coll Cardiol (2009) 2.96

Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC). Circulation (2009) 2.66

Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis. Heart (2010) 2.42

Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care (2010) 2.42

Lower testosterone levels predict incident stroke and transient ischemic attack in older men. J Clin Endocrinol Metab (2009) 2.01

High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden. J Am Coll Cardiol (2011) 1.81

Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care (2014) 1.42

Risk of Myocardial Infarction in Older Men Receiving Testosterone Therapy. Ann Pharmacother (2014) 1.25

Myocardial structure, function, and scar in patients with type 1 diabetes mellitus. Circulation (2011) 1.20

Contrasting testosterone concentrations in type 1 and type 2 diabetes. Diabetes Care (2006) 1.18

Global trends in testosterone prescribing, 2000-2011: expanding the spectrum of prescription drug misuse. Med J Aust (2013) 1.12

Association between cardiovascular autonomic neuropathy and left ventricular dysfunction: DCCT/EDIC study (Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications). J Am Coll Cardiol (2012) 1.00

Neuroactive steroids and peripheral neuropathy. Brain Res Rev (2007) 0.94

Cardiovascular autonomic neuropathy and subclinical cardiovascular disease in normoalbuminuric type 1 diabetic patients. Diabetes (2012) 0.93

Low testosterone level as a predictor of cardiovascular events in Japanese men with coronary risk factors. Atherosclerosis (2009) 0.92

A J-shaped association between plasma testosterone and risk of ischemic arterial event in elderly men: the French 3C cohort study. Maturitas (2013) 0.89

A review of the relationships between endogenous sex steroids and incident ischemic stroke and coronary heart disease events. Curr Cardiol Rev (2015) 0.85

Cardiovascular autonomic neuropathy, erectile dysfunction and lower urinary tract symptoms in men with type 1 diabetes: findings from the DCCT/EDIC. J Urol (2015) 0.83

Circulating testosterone and estradiol, autonomic balance and baroreflex sensitivity in middle-aged and elderly men with heart failure. Aging Male (2013) 0.82

Prevalence of low testosterone and predisposing risk factors in men with type 1 diabetes mellitus: findings from the DCCT/EDIC. J Clin Endocrinol Metab (2014) 0.81

Sex steroids and heart rate variability in patients after myocardial infarction. Ann Noninvasive Electrocardiol (2004) 0.80

Age, insulin requirements, waist circumference, and triglycerides predict hypogonadotropic hypogonadism in patients with type 1 diabetes. J Sex Med (2014) 0.77